Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (Q61906964)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine |
clinical trial |
Statements
RVF (English)
0 references
A Phase 2 Open Label Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated, Dried, TSI-GSD 200, Lot 7, Run 2, in Adult Subjects at Risk of Exposure to Rift Valley Fever Virus (English)
0 references
4 October 2018
0 references
December 2023
0 references
500
0 references
18 year
0 references
65 year
0 references